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Summary
patent ductus arteriosus (pDA) is one of the most 
common diagnosed congenital disease in dogs that 
usually causes heart failure and death unless corrected 
at a young age. A 2.5- year- old female intact Coton 
de tuléar was referred and diagnosed with a left to 
right shunt pDA. Closure of the pDA was performed 
via a minimally invasive approach by means of an 
Amplatz canine duct occluder device. in this case 
report, we describe a successful anaesthetic protocol 
that included premedication using a combination of 
acepromazine and methadone, induction with propofol 
and midazolam and maintenance with isoflurane in 
oxygen, as well as a lidocaine constant rate constant rate 
infusion for intraoperative analgesic and cardiovascular 
support. this protocol provided excellent intraoperative 
cardiopulmonary stability and a smooth and rapid 
recovery.
BaCkground
The ductus arteriosus (DA) is a blood vessel that 
in the fetus connects the main pulmonary artery to 
the proximal descending aorta. This vessel usually 
closes at birth when pulmonary respiration starts 
and placental blood flow is removed. It is described 
that in dogs the anatomical closure of the DA should 
occur between 48 hours and 1 month after birth.1 
A patent ductus arteriosus (PDA) is a congenital 
disease where the connection between the pulmo-
nary artery and the aorta remains patent after birth 
because of incomplete encirclement of the ductus 
by smooth muscle tissue.2 3
Diagnosis can be performed by means of phys-
ical examination, echocardiography and thoracic 
radiographs. During cardiac auscultation, a typical 
continuous (‘machinery’) murmur can be distin-
guished cranially at the left hemithorax, at the level 
of the heart base. This specific murmur is considered 
to be almost pathognomonic for the presence of a 
PDA in dogs. Despite this specific murmur, echo-
cardiography is the preferred modality to confirm 
the diagnosis and quantify cardiac volume overload, 
as well as to exclude other concurrent congenital 
malformations. Radiography is indispensable for 
assessment of pulmonary congestion or possible 
cardiogenic pulmonary oedema.
Treatment consists of closure of the PDA. Tradi-
tionally, PDAs have been corrected surgically by 
ligation of the defect in both dogs4 5 and humans6 
through a thoracotomy approach. Ever since, 
minimally invasive techniques have been devel-
oped, which involve the use of thrombogenic coils 
or intravascular occluding devices such as duct 
occluder or vascular plugs.7–9
The choice for a specific technique depends on 
patient size, as well as the size and shape of the 
defect and the owner’s preference.
In literature, many studies were performed in 
order to evaluate the outcome of the different 
procedures; nevertheless, only a few case reports 
are available which concentrate on the anaesthetic 
challenge and describe the protocol that might be 
best suitable in these cases.
This case report describes the anaesthetic 
management for PDA occlusion in a dog using the 
minimally invasive insertion of an Amplatz canine 
duct occluder (ACDO) device.
CaSe preSenTaTion
A 2.5- year- old female intact Coton de Tuléar 
weighing 6.2 kg was referred to the small animal 
department at the faculty of veterinary medicine 
of Ghent University (Belgium) for further investi-
gation of a suspected PDA following detection of a 
continuous ‘machinery’ heart murmur IV/VI with 
the point of maximum intensity on the left heart 
base. There was no history of respiratory distress, 
coughing or exercise intolerance. Besides the afore-
mentioned murmur, the physical examination was 
unremarkable.
Echocardiographic examination confirmed the 
presence of a left- to- right shunting PDA, mild 
volume overload of the left ventricle and mild dila-
tion of the left atrium. The ampulla of the PDA 
measured 4.9 mm, while the isthmus was 2.2 mm. 
Concurrently, a mild mitral valve regurgitation was 
observed, most likely due to annulus dilation of the 
mitral valve secondary to the volume overload. A 
full blood work including biochemistry, haema-
tology, coagulation times and electrolytes concen-
trations did not reveal any abnormalities.
Patient size and ductal diameter of the PDA 
enabled transarterial occlusion of the ductus by 
means of an ACDO. This was considered the least 
invasive way to close the PDA, and the procedure 
was scheduled 3 weeks after the first consult.
On the day of the procedure, the preanaesthetic 
examination was unremarkable. The patient was 
classified as American Society of Anesthesiologists 
III (patient with a severe systemic disease that is 
not life- threatening). After aseptic preparation of 
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the skin and placement of a 22G intravenous catheter (Optiva; 
Smiths Medical, UK) in the left cephalic vein, the patient was 
premedicated with acepromazine 5 µg/kg (Placivet; Kela N.V., 
Hoogstraten, Belgium) and intravenous methadone 0.2 mg/
kg (Comfortan; Dechra Veterinary Products, Belgium). Twenty 
minutes after premedication and after 3 min of preoxygenation 
using a face mask and pure oxygen flow on 2 L/min, anaesthesia 
was induced using a combination of midazolam hydrochloride 
0.2 mg/kg (Dormicum; Roche, Netherlands) and intravenous 
propofol 2 mg/kg (PropoVet, Zoetis, Belgium). After endotra-
cheal intubation using a 6- mm internal diameter cuffed endo-
tracheal tube (Endotracheal PVC tube, Kruuse, Belgium), 
anaesthesia was maintained with isoflurane (IsoFlo 100%, 
Zoetis) in oxygen using a circle breathing system and an end tidal 
isoflurane between 1.1% and 1.3%. After induction of anaes-
thesia, the patient was prepared for surgery. At the same time, 
a 22G intravascular catheter was placed under aseptic condi-
tions in the left dorsal pedal artery and connected to a pressure 
transducer, which had been zeroed to atmospheric pressure. The 
transducer was positioned at the level of the right atrium. Venti-
lation of the patient was spontaneous during the first 30 min of 
anaesthesia (corresponding to the surgical preparation period), 
while intermittent positive pressure mechanical ventilation was 
started as soon as the patient was placed on the surgical table and 
connected to the anaesthetic ventilator in the surgical theatre 
(Draeger Ventilog 3, Technimed, Belgium). In order to main-
tain normocapnia (end tidal CO2 35–45 mm Hg), the following 
settings were used: tidal volume 10 mL/kg, respiration rate 16 
breaths/min and peak inspiratory pressure 9 cmH2O. No changes 
in these settings were made during maintenance of anaesthesia. 
Monitoring consisted of side stream capnography, pulse oxim-
etry (probe placed on the tongue), measurement of inspired and 
expired concentrations of oxygen and isoflurane, heart rate (HR) 
and arrhythmia analysis using electrocardiography, oesophageal 
temperature and systolic arterial pressure (SAP), diastolic arterial 
pressure (DAP) and mean arterial pressure (MAP) using a multi-
parameter monitor (Datex Ohmeda S/5, Finland). All data were 
recorded every 10 min. Temperature was maintained using a 
forced warm air device (Mistral Air Plus, The Surgical Company 
International B.V., Netherlands) attached to the operating table. 
Cefazoline 22 mg/kg (Cefazoline Sandoz, Sandoz nv/sa, Belgium) 
and carprofen 4 mg/kg (Rimadyl, Zoetis, Belgium) were admin-
istered intravenously 20 min before the start of the surgery. A 
lidocaine hydrochloride (Xylocaïne 2%, Astra Zeneca, UK) 
constant rate infusion (CRI) was started 20 min after induction 
with a loading bolus of 2 mg/kg and administered intravenously 
at a rate of 30 µg/kg/min during the entire procedure. Further-
more, Hartmann’s solution (Hartmann Braun, Braun Medical, 
België) was intravenously infused throughout anaesthesia at a 
rate of 5 mL/kg/hour. An incision of the skin at the medial aspect 
of the right femur was made after infiltration of the skin with 
2 mg/kg of lidocaine hydrochloride. The right femoral artery was 
subsequently catheterised and an ACDO (Infinity Medical) was 
placed at the level of the ampulla of the PDA as described in 
literature.10 11 The position of the PDA, the correct placement of 
the device and the accurate closure of the defect were guided and 
confirmed by means of fluoroscopy and angiography. The proce-
dure lasted 150 min. One fentanyl bolus of 2 µg/kg (Fentadon; 
Dechra Veterinary Products, Belgium) was needed and admin-
istered intravenously just after the start of the procedure due 
to a sudden increase in HR and MAP (respectively, from 82 to 
100 beats/min and from 72 to 86 mm Hg). Otherwise, during 
the entire procedure, all the parameters remained within physi-
ological ranges. SAP, DAP and MAP increased, while HR mildly 
decreased after occlusion of the PDA as a consequence of the 
Branham reflex. A more pronounced dicrotic notch in the arte-
rial blood pressure waveform was observed at the same moment. 
At the end of the procedure, a radiograph was taken in order to 
further confirm the correct position of the device. The patient 
was recovered in the intensive care unit where he continued 
to breathe 100% oxygen for around 30 min after the end of 
anaesthesia and received intravenous buprenorphine 0.02 mg/
kg (Vetergesic, Ceva Santé Animale S.A., Belgium) every 6 hours 
for postoperative analgesia. Recovery from anaesthesia was 
uneventful and the dog appeared comfortable. The endotracheal 
tube was removed when the dog started to swallow. The patient 
was sent home 3 days postoperatively.
ouTCome and follow-up
One day postoperatively, the patient underwent an echocardio-
graphic control examination which confirmed correct placement 
of the device with consequent absent flow through the PDA. At 
a control visit at 1 and 6 months postoperatively the patient was 
doing well, with the ACDO device in the same position, without 
any residual flow present.
diSCuSSion
This case report describes the anaesthetic management of a 
successful intravascular occlusion of a PDA in a dog.
A PDA is a congenital disease in dogs in which the DA fails 
to close after birth and causes therefore a direct connection 
between the pulmonary artery and the aorta. The closure of the 
DA is induced by the natural decrease in pulmonary vascular 
resistance (PVR) and increase in systemic vascular resistance 
(SVR) that occurs after birth.12
In the present case, due to the PDA diameter and patient size, 
the duct was occluded by means of an intravascular ACDO. This 
self- expandable two- disk device is able to adapt to the shape of 
the PDA and is used to occlude medium- sized PDAs.9 Potential 
major complications associated with this kind of intra- arterial 
devices include dislodgement or embolisation of the device into 
the pulmonary or arterial system, inadvertent damage to the 
aorta or other major blood vessels, leading to haemorrhage and 
ductal reopening through the device.13 Nevertheless, the compli-
cation rate associated with the use of these devices is low (as low 
as 3%), and the success rate (complete cessation of ductal flow) 
is reported to be 92%.14
Anaesthesia in dogs with PDA may be a challenge for the 
anaesthetist, even though these patients are mainly young and 
otherwise in good health. The magnitude and direction of shunt 
flow is controlled by the relationship between the SVR and PVR, 
the latter being usually substantially lower than the former one 
and giving rise to the typical left to right shunt that decreases 
DAP despite a normal SAP in the majority of patients with PDA 
patients. Most of the existing anaesthetic agents affect both PVR 
and SVR. Assuming pulmonary pressure remains unchanged, an 
increase in SVR (ie, peripheral vasoconstriction) will increase 
DAP but will also increase the left to right shunt flow, which 
may cause an overload of the pulmonary circulation. On the 
other side, a reduction in SVR (ie, peripheral vasodilation) will 
reduce left to right shunt flow but may also cause severe hypo-
tension because of a further decrease in DAP that can lead to 
shunt reversal (right to left) and life- threatening hypoxaemia. 
Therefore, the goal of the anaesthetist is to ensure organ perfu-
sion by maintaining cardiac output and arterial blood pressure 
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learning points
 ► Ideal anaesthetic protocol for patent ductus arteriosus 
closure: choose products in order to minimise haemodynamic 
and ventilatory alterations.
 ► Ensure organ perfusion and avoid shunt reversal by 
maintaining a stable cardiac output and arterial blood 
pressure.
 ► Minimally invasive intra- arterial approach: re- evaluation of 
the role of acepromazine as low dosages of this compound 
might also partially counteract the mechanically induced 
increase in systemic vascular resistance that can be 
encountered with the insertion and advancement of the 
guiding sheath and intravascular device into the femoral 
artery up to the proximal descending aorta.
with no to minimal changes in PVR and SVR and therefore avoid 
shunt reversal.15
Generally, anaesthetics which have less cardiovascular (side) 
effects should be used to perform general anaesthesia in patients 
with PDA.
In the present case, premedication was performed using a 
combination of acepromazine (0.005 mg/kg) and methadone 
(0.2 mg/kg-1) IV 20 min prior to induction, which achieved a 
good sedation with unremarkable cardiovascular changes.
Due to the profound reduction in HR and cardiac output and 
the significant vasoconstriction induced increase in afterload and 
SVR, alpha-2 agonists are contraindicated for premedication in 
these patients. Furthermore, also acepromazine and other pheno-
thiazines might not always be recommended. The vasodilation- 
induced reduction in SVR and thus hypotensive properties of 
these agents can lead to shunt reversal if the pulmonary arterial 
pressure exceeds the aortic pressure.15 Nevertheless, the vaso-
dilatory effect of acepromazine is dose dependent16 and small 
doses of acepromazine (2–5 µg/kg) may be beneficial, as a mild 
reduction in SVR can increase systemic blood flow and reduce 
shunting before ligation.15 Furthermore, different studies have 
demonstrated that usage of acepromazine in premedication 
achieves good anxiolysis and a great level of sedation (espe-
cially when combined with an opioid agent), dose reduction of 
induction and maintenance agents and smoother recoveries, and 
also protects the heart against catecholamine- induced arryth-
mias.16–18 Similarly, also the use of opioids has a dose- sparing 
effect on induction and maintenance agents. Nevertheless, care 
must be taken when opioids are used, since they can produce 
bradycardia due to a centrally mediated enhanced activity in 
parasympathetic neurons innervating the heart. However, when 
clinically relevant dosages are used, this bradycardia is mild 
and cardiac output is usually maintained by an increased stroke 
volume.19
In this case, the idea behind the use of a low dose of 
acepromazine was not only to achieve a good sedation with 
acceptable cardiovascular changes (which are dose dependent). 
As stated before, a low dose of acepromazine may increase 
systemic blood flow and reduce shunting before ligation, and 
it could also be hypothesised that these low dosages might also 
partially counteract the mechanically induced increase in SVR 
that can be encountered with the insertion and advancement 
of the guiding sheath and intravascular device into the femoral 
artery up to the proximal descending aorta. To the authors’ 
knowledge, no literature is available to confirm or disap-
prove this theory. Interestingly, in a case report from 2012 
which compared the anaesthetic management of PDA closure 
by means of surgical ligation in one patient and transarterial 
occlusion in the second patient, a combination of aceprom-
azine with pethidine for intramuscular premedication was 
used in the patient undergoing surgical ligation, while the dog 
undergoing transarterial occlusion of the PDA received only 
pethidine intramuscularly.20
Also at induction of anaesthesia, reduction of SVR and 
therefore hypotension, with possible shunt reversal, should be 
avoided. Propofol, which was used for induction of anaesthesia 
in combination with midazolam, can reduce SVR and blood 
pressure because of a decrease in sympathetic activity, direct 
vasodilatation and myocardial depression.15 21–23 Nevertheless, 
the vasodilation seems to be dependent on the dose adminis-
tered and the rate of its administration.24 25 It is also known that 
the coadministration of a sedative drug, like a benzodiazepine, 
during induction, decreases the dose of propofol required, and 
therefore the related cardiopulmonary depression.26 27
Possible alternatives to propofol are the administration of 
alfaxalone or etomidate. Even though alfaxalone has been shown 
to cause a decrease in arterial blood pressure, it has been demon-
strated that baseline MAP tended to be restored earlier compared 
with dogs that received propofol.28 Furthermore, when alfax-
alone was administered at clinically relevant doses, cardiovas-
cular and respiratory parameters remained quite stable.29 On the 
other side, also etomidate administration in healthy patients is 
well known for its cardiovascular stability. In a study comparing 
the cardiorespiratory effects of induction with etomidate or 
alfaxalone in healthy dogs, etomidate did not produce signifi-
cant cardiovascular changes, while alfaxalone caused statistically 
significant tachycardia, which was clinically significant for a 
short period of time. Moreover, alfaxalone caused an increase 
in cardiac output and small (clinically insignificant) decreases 
in SVR and arterial blood pressures.30 However, an increased 
frequency of adverse reactions during induction, as well as 
rougher recoveries, have been associated with etomidate induc-
tion.31 For this case a combination of propofol (2 mg/kg) and 
midazolam (0.2 mg/kg) achieved a smooth and stable induction 
for orotracheal intubation and instrumentation prior to surgery.
For the maintenance of anaesthesia, isoflurane vapo-
rised in oxygen was used in this case. Inhalation agents cause 
concentration- dependent cardiorespiratory depression such as 
hypoventilation and hypotension.32 Several studies have demon-
strated that the concurrent administration of different agents, 
such as opioids and local anaesthetics, achieves a good decrease 
of the minimal alveolar concentration (MAC) of inhalants and 
therefore reduce the associated cardiorespiratory depression.33 34 
In this case, a CRI of lidocaine was administered throughout 
the entire procedure as part of a balanced multimodal analgesia. 
This local anaesthetic, when administered as a CRI, provides 
analgesia and has antiarrhythmic effects on top of the aforemen-
tioned inhalants MAC reduction.33 35
The decrease in HR and the more pronounced dicrotic notch 
immediately after the intravascular closure of the defect is a 
consequence of the well- described Branham reflex, a baroceptor 
response to the increase in MAP and change in SVR.36 37 Never-
theless, in this case, the changes were only mild and kept in phys-
iological ranges, without the need for any further treatment.
In conclusion, based on the available literature, it can be stated 
that an ideal anaesthetic protocol in a patient with a PDA should 
minimise haemodynamic and ventilatory alterations, to preserve 
a good perfusion of the organs throughout the procedure. In 
the case described, the intravenous administration of aceproma-
zine and methadone in premedication, the intravenous induction 
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with propofol and midazolam, as well as the lidocaine CRI as a 
support during maintenance with isoflurane in oxygen, was easy 
to perform and provided excellent intraoperative conditions and 
a smooth and rapid recovery.
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